Penserra Capital Management LLC Seres Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$6.02 - $11.43 $12,642 - $24,003	-2,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $81 - $339	15 Added 0.72%	2,100 $14,000
Q2 2021 Aug 12, 2021	BUY	$18.46 - $24.36 $461 - $609	25 Added 1.21%	2,085 $49,000
Q1 2021 May 13, 2021	SELL	$17.66 - $28.92 $618 - $1,012	-35 Reduced 1.67%	2,060 $42,000
Q4 2020 Feb 12, 2021	BUY	$23.25 - $37.73 $30,945 - $50,218	1,331 Added 174.21%	2,095 $51,000
Q3 2020 Nov 13, 2020	BUY	$3.74 - $28.74 $2,857 - $21,957	764 New	764 $21,000

41M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $104M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.